These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2307401)

  • 1. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
    Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
    Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC; Feu F; Bosch J; Rodés J
    Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A; Feu F; Bordas JM; García-Pagán JC; Luca A; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension.
    García-Pagán JC; Feu F; Navasa M; Bru C; Ruiz del Arbol L; Bosch J; Rodés J
    J Hepatol; 1990 Sep; 11(2):189-95. PubMed ID: 2123914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
    Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
    J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
    Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
    Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
    Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
    Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.
    Bellis L; Berzigotti A; Abraldes JG; Moitinho E; García-Pagán JC; Bosch J; Rodés J
    Hepatology; 2003 Feb; 37(2):378-84. PubMed ID: 12540788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M; Chesta J; Bosch J; Rodés J
    Gastroenterology; 1989 Apr; 96(4):1110-8. PubMed ID: 2925055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing actions of the acute administration of propranolol and isosorbide-5-mononitrate on the portal circulation.
    Forrest EH; Jalan R; Redhead DN; Hayes PC
    Aliment Pharmacol Ther; 1996 Oct; 10(5):795-800. PubMed ID: 8899089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol plus prazosin compared with propranolol plus isosorbide-5-mononitrate in the treatment of portal hypertension.
    Albillos A; García-Pagán JC; Iborra J; Bandi JC; Cacho G; Pérez-Paramo M; Escorsell A; Calleja JL; Escartín P; Bosch J
    Gastroenterology; 1998 Jul; 115(1):116-23. PubMed ID: 9649466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
    J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect and mechanism of action of isosorbide-5-mononitrate.
    Hayes PC; Westaby D; Williams R
    Gut; 1988 Jun; 29(6):752-5. PubMed ID: 3384359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-isosorbide mononitrate and propranolol on subclinical hepatic encephalopathy and renal function in patients with liver cirrhosis.
    Silva G; Segovia R; Ponce R; Backhouse C; Palma M; Roblero JP; Abadal J; Quijada C; Troncoso M; Iturriaga H
    Hepatogastroenterology; 2002; 49(47):1357-62. PubMed ID: 12239942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension.
    Mols P; Hallemans R; Melot C; Lejeune P; Naeije R
    J Hepatol; 1989 May; 8(3):316-24. PubMed ID: 2732445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.